mefenamic acid + paracetamol

Oragesic is a combination pharmaceutical product developed and marketed by Navil Laboratories, primarily used as an analgesic and antipyretic. It consists of mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID) belonging to the fenamate class, and paracetamol (acetaminophen). Mefenamic acid functions by inhibiting the cyclooxygenase enzymes (COX-1 and COX-2), which are responsible for the production of prostaglandins that mediate pain, fever, and inflammation. Paracetamol provides additional analgesic and antipyretic effects, likely through the inhibition of prostaglandin synthesis in the central nervous system. The combination is indicated for the treatment of mild to moderate pain, including headache, dental pain, and musculoskeletal pain, as well as for reducing fever.

Brand names

Oragesic

Other names

mefenamic acid + acetaminophen